Protect Pharmaceutical Corporation
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name… Read more
Protect Pharmaceutical Corporation (PRTT) - Total Liabilities
Latest total liabilities as of June 2025: $77.42 Million USD
Based on the latest financial reports, Protect Pharmaceutical Corporation (PRTT) has total liabilities worth $77.42 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Protect Pharmaceutical Corporation - Total Liabilities Trend (2009–2024)
This chart illustrates how Protect Pharmaceutical Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Protect Pharmaceutical Corporation Competitors by Total Liabilities
The table below lists competitors of Protect Pharmaceutical Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ayalon Holdings Ltd
TA:AYAL
|
Israel | ILA17.44 Billion |
|
Tiny Ltd.
PINK:TNYZF
|
USA | $246.43 Million |
|
Acceleware Ltd
PINK:ACWRF
|
USA | $6.37 Million |
|
Lippo General Insurance Tbk
JK:LPGI
|
Indonesia | Rp1.96 Trillion |
|
Canaf Investments Inc
PINK:CAFZF
|
USA | $1.77 Million |
|
Keyware Technologies NV
BR:KEYW
|
Belgium | €7.26 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Protect Pharmaceutical Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Protect Pharmaceutical Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Protect Pharmaceutical Corporation (2009–2024)
The table below shows the annual total liabilities of Protect Pharmaceutical Corporation from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $84.94 Million | -5.62% |
| 2023-12-31 | $90.00 Million | -21.38% |
| 2022-12-31 | $114.47 Million | -28.73% |
| 2021-12-31 | $160.61 Million | +1037.06% |
| 2020-12-31 | $14.13 Million | +21926.76% |
| 2019-12-31 | $64.13K | +27.54% |
| 2018-12-31 | $50.28K | -64.95% |
| 2017-12-31 | $143.44K | +588.63% |
| 2016-12-31 | $20.83K | -79.26% |
| 2015-12-31 | $100.45K | -17.31% |
| 2014-12-31 | $121.48K | -79.61% |
| 2013-12-31 | $595.81K | +3.07% |
| 2012-12-31 | $578.05K | +29.11% |
| 2011-12-31 | $447.73K | -2.50% |
| 2010-12-31 | $459.20K | +8678.49% |
| 2009-12-31 | $5.23K | -- |